Results 161 to 170 of about 2,225,395 (290)

Chemotherapy‐Activated GSK3β‐DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma

open access: yesAdvanced Science, EarlyView.
Temozolomide treatment activates GSK3β, driving DNMT1 phosphorylation, destabilization, and CD47 promoter hypomethylation in glioblastoma. This epigenetic shift upregulates CD47, enabling TMZ‐treated GBM cells to evade macrophage phagocytosis, survive chemotherapy, and acquire resistance.
Jie Li   +11 more
wiley   +1 more source

YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple‐Negative Breast Cancer

open access: yesAdvanced Science, EarlyView.
Lai et al. find that m6A reader YTHDC1 is specifically overexpressed in triple‐negative breast cancer (TNBC) and orchestrates glucose and glutamine metabolism in an m6A‐dependent manner to confer robust adaptability to lethal metabolic stress. Leveraging YTHDC1 knockdown‐induced metabolic vulnerability, an ATF4 mRNA‐targeted nanotherapy is developed to
Zheng‐Hao Lai   +12 more
wiley   +1 more source

Nanodelivery Systems as Innovative Approaches to Modulate Macrophage Polarization in Oral Inflammatory Diseases and Oral Cancer

open access: green
Adina Bianca Boşca   +9 more
openalex   +1 more source

1114 Orally bioavailable small-molecule RXFP1 agonist TRND8394 potentiates immunotherapy in breast cancer models [PDF]

open access: gold
Alexander I. Agoulnik   +9 more
openalex   +1 more source

Situación epidemiológica del cáncer oral : estudios de prevalencia y mortalidad en Chile

open access: yes, 2011
Tesis (Cirujano Dentista, especialización en Odontopediatría)Introducción: En Chile la morbilidad por cáncer oral y faríngeo corresponde a un 1,6% del total de los canceres, pero no contamos con registros de incidencia ni prevalencia; básicos para la ...
González Poblete, Katherinne Andrea
core  

Discovery and Optimization of AMT‐676, a CDH17‐Targeting ADC for the Treatment of Advanced Gastrointestinal Cancers

open access: yesAdvanced Science, EarlyView.
AMT‐676 is a novel antibody‐drug conjugate targeting CDH17, an adhesion molecule uniquely exposed on gastrointestinal tumor surfaces. Engineered with an optimized exatecan payload, it demonstrates profound tumor regression and a robust bystander effect across diverse preclinical models.
Ying‐nan Wang   +21 more
wiley   +1 more source

79 Premalignant oral dysplasias that progress to cancer are distinguished by spatially organized T cell responses [PDF]

open access: gold
Jingya Qiu   +26 more
openalex   +1 more source

Perfil clínico del cáncer oral, en los pacientes tratados en la unidad de estomatología oral y maxilofacial, hospital universitario San Vicente de paúl, 2005 - 2007.

open access: yes, 2008
El cáncer oral es uno de los tipos de cáncer más destructivos por su rapidez en el crecimiento y su potencial de metástasis. La remoción quirúrgica puede causar una destrucción facial y una disfunción importante que conlleva a un impacto en la calidad ...
Murillo Garcia, Jonny Andres   +2 more
core  

DLST Succinylation‐Mediated Mitochondrial Metabolic Remodeling and Cuproptosis Resistance Promote Malignant Progression of Lung Adenocarcinoma

open access: yesAdvanced Science, EarlyView.
The DLST K409 succinylation mediated by CPT1A promotes OXPHOS and redox homeostasis through regulating enzyme activity, thereby promoting the malignant progression of LUAD. Notably, the succinylation of DLST can enhance the cuproptosis resistance by inhibiting its lipoylation.
Xuanxuan Li   +9 more
wiley   +1 more source

TOMM5 is associated with oral cancer progression: a multi-omics analysis from single-cell atlas to in vitro validation. [PDF]

open access: yesFuture Sci OA
Gao L   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy